Fenwal, Inc. is a global medical technology company specializing in blood collection, separation, storage, and transfusion products for transfusion medicine and cell therapies. Based in Lake Zurich, Illinois, the company's portfolio includes manual and automated blood-collection systems, apheresis technologies, plasma exchange systems, and blood storage equipment. Originally founded as Fenwal Laboratories in 1949, the company became an independent entity in 2007 following its divestiture from Baxter Healthcare Corporation and was subsequently acquired by Fresenius Kabi in 2012. Fenwal's products and technologies are used by blood centers, plasma collectors, and hospitals across six continents to enhance blood safety and availability.
| Import | Export |
|---|---|
|
Trade Records
841
|
Trade Records
85
|
|
Suppliers
5
|
Buyers
4
|
|
Latest Import Date
2026-07
|
Latest Export Date
2026-04
|
According to Topease's global trade data, FENWAL INC. exports products to verified importers across global markets.
Its export activity is associated with HS-code categories such as:
Representative importers include:
These export insights help users understand the FENWAL INC. distribution footprint, product specialization, and shipment scale. Through Topease's deep trade data and trade intelligence capabilities—such as trade flow analysis and market benchmarking—importers and exporters can evaluate downstream demand and identify potential importer relationships.
As an importer, FENWAL INC. sources products from verified exporters across multiple regions.
Its import activity spans HS-code categories including:
Representative exporters include:
- FENWAL INTERNATIONAL INC.
- FRESENIUS MEDICAL CARE DE MEXICO S.A. DE C.V.
- FRESENIUS KABI HORATEV CZ S.R.O.
These import insights help users assess sourcing patterns, supplier concentration, and trade continuity. With Topease's analytical tools—such as sourcing pattern analysis and supply-chain mapping—users can evaluate supplier performance and identify diversification opportunities.
Explore FENWAL INC.'s import activity, including trade volumes, top suppliers, sourcing countries, and key product categories. These insights allow exporters and potential suppliers to understand its global supply chains, track procurement trends, and identify new business opportunities.
| Exporter | Importer | HS Code | Number of Trade | Amount (USD) | Quantity | Import Port |
|---|---|---|---|---|---|---|
| FENWAL INTERNATIONAL INC. | FENWAL INC. | 3907 | 24 | $186,500 | 3,420 | Los Angeles |
| FRESENIUS MEDICAL CARE DE MEXICO S.A. DE C.V. | FENWAL INC. | 3824 | 24 | $186,500 | 3,420 | Los Angeles |
| PT. VOLEX INDONESIA | FENWAL INC. | 8544 | 24 | $186,500 | 3,420 | Los Angeles |
| FABRICATORS INTERNATIONAL LTD | FENWAL INC. | 8504 | 24 | $186,500 | 3,420 | Los Angeles |
| FRESENIUS KABI HORATEV CZ S.R.O. | FENWAL INC. | 9018 | 24 | $186,500 | 3,420 | Los Angeles |
Gain insights into FENWAL INC.'s export activities, including shipment volumes, key buyers, destination countries, and product categories. Understand global demand patterns, track sales reach, and spot opportunities to connect with potential buyers.
| Importer | Exporter | HS Code | Number of Trade | Amount (USD) | Quantity | Export Port |
|---|---|---|---|---|---|---|
| FRESENIUS KABI CHINA CO. LTD. | FENWAL INC. | 9018 | 24 | $186,500 | 3,420 | Los Angeles |
| FENWAL INTERNATIONAL INC. | FENWAL INC. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| FRESENIUS KABI MEXICO S.A. DE C.V. | FENWAL INC. | 7616 | 24 | $186,500 | 3,420 | Los Angeles |
| FRESENIUS MEDICAL CARE DE MEXICO S.A. DE C.V. | FENWAL INC. | 3824 | 24 | $186,500 | 3,420 | Los Angeles |
Chain Insights — Explore FENWAL INC.'s trading network to uncover connections with international buyers and suppliers. With Topease's Supply Chain Solution, you can track product flows and identify patterns that reveal new sourcing and partnership opportunities.
Access FENWAL INC.'s key professional contacts for B2B outreach purposes. View verified phone numbers, emails, and LinkedIn profiles to facilitate efficient business communication.
Disclaimer: Data is compiled from public and third-party sources and may not be complete or fully accurate. This information is provided for business intelligence purposes only and should not be used for legal, financial, or compliance decisions.